Predicting response to biologics for severe asthma through breath analysis
Researchers at the University of Liège have developed a breath analysis method to predict how patients with severe asthma will respond to biologic therapies. This 'breathomics' approach aims to personalize treatment plans by identifying molecular signatures.
Why it matters
Improving the precision of asthma treatment can significantly reduce healthcare costs and improve patient quality of life by avoiding ineffective medications.
edited by Gaby Clark , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in